Effect of a Novel NMDA Receptor Modulator, Rapastinel (Formerly GLYX-13), in OCD: Proof of Concept.

Effect of a Novel NMDA Receptor Modulator, Rapastinel (Formerly GLYX-13), in OCD: Proof of Concept. Am J Psychiatry. 2016 Dec 01;173(12):1239-1241 Authors: Rodriguez CI, Zwerling J, Kalanthroff E, Shen H, Filippou M, Jo B, Simpson HB, Burch RM, Moskal JR PMID: 27903098 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/27903098?dopt=Abstract

Source: The American Journal of Psychiatry - November 30, 2016 Category: Psychiatry Authors: Rodriguez CI, Zwerling J, Kalanthroff E, Shen H, Filippou M, Jo B, Simpson HB, Burch RM, Moskal JR Tags: Am J Psychiatry Source Type: research

More News: Psychiatry